National Cancer Institute
Cancer Control & Population Sciences Home - NCI's Bridge to Public Health Research, Practice and Policy

Grant Details

Grant Number: 5R01CA033449-03 Interpret this number
Primary Investigator: Rinehart, John
Organization: Ohio State University
Project Title: Liposome-Macrophage Activating Factor for Clinical Use
Fiscal Year: 1984
Back to top


Abstract

An abstract does not currently exist for this grant

Back to top


Publications

Characterization and modulation of human lymphokine (interleukin 2) activated killer cell induction.
Authors: Hoyer M, Meineke T, Lewis W, Zwilling B, Rinehart J
Source: Cancer Res, 1986 Jun;46(6), p. 2834-8.
PMID: 2421884
Related Citations

Grant Numbers:
NCI NIH HHS - CA09338 NCI NIH HHS - CA33449-03

MeSH Terms:
Cytotoxicity, Immunologic Interleukin-1 Tritium
Interleukin-2 Kinetics Killer Cells, Natural
Humans Interferons Leucine
Monocytes Phenylalanine Thymidine

Back to top


Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Authors: Sadlik JR, Hoyer M, Leyko MA, Horvat R, Parmely M, Whitacre C, Zwilling B, Rinehart JJ
Source: Cancer Res, 1985 May;45(5), p. 1940-5.
PMID: 3921233
Related Citations

Grant Numbers:
NCI NIH HHS - CA09338 NCI NIH HHS - CA33449-03

MeSH Terms:
Antibodies, Monoclonal Cytotoxicity, Immunologic Interferon-gamma
Humans Chromatography, Liquid Macrophage-Activating Factors
Monocytes Lymphocytes Lymphokines

Back to top




Last Updated: August 24, 2012
NIH - Turning Discovery Into Health
National Cancer InstituteU.S. National Institutes of HealthNational Cancer Institute